Radboudumc
Hospitals & Physicians Clinics · Netherlands · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Geert Grooteplein Zuid 10, Nijmegen, Gel...Phone Number
+31 243611111Website
www.radboudumc.nlRevenue
$2.7 BillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
4
7
5
3
3
About Radboudumc
Radboudumc is one of eight University Medical Centres in The Netherlands, founded in 1951. The institution is devoted to patient care, education, training, and conducting basic and clinical research. Radboudumc focuses on delivering participatory and personalized healthcare through innovative medical services and research and development initiatives. The center maintains a strong emphasis on collaboration with various stakeholders including companies, patient organizations, and policy makers to maximize healthcare impact. With facilities across multiple locations in Europe, Radboudumc offers comprehensive medical services supported by advanced technology and mobile applications.Explore more
Radboudumc Org Chart
MH
Manager
KH
Manager
DV
Manager
FA
Manager
FC
Manager
SS
Manager
MF
Manager
SS
Manager
HW
Manager
KE
Sales Manager
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Radboudumc your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Radboudumc launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Radboudumc had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Radboudumc has new funding data
Earning: See what the market has to say on Radboudumc recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Radboudumc is spiking on competitors!
Radboudumc, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Radboudumc
Check if Radboudumc has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Radboudumc
Find 2 more new buyers
Company Profile Activity
Activity Insights
Radboudumc is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Radboudumc is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Radboudumc.
Radboudumc Tech Stack
A closer look at the technologies used by Radboudumc
Most Recent Scoops
Hiring Plans
Radboudumc has more open roles in Finance than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Hiring Plans
Radboudumc has more open roles in Legal than it has had at any time in the past 12 months.
Hiring Plans
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Radboudumc News & Media
Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks' proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform TGW211 is designed to achieve strong tumor uptake with selective and rapid elimination of...Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
TGW211 is a next-generation, first-in-class HER2-directed radioimmunoconjugate developed based on Tagworks' proprietary Click-to-Release – bioorthogonal, in vivo click chemistry – linker platform TGW211 is designed to achieve strong tumor uptake with selective and rapid elimination of...PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics. The study demonstrates the impact of PacBio’s HiFi long-read sequencing technology in identifying genetic causes of rare diseases, illustrating the feasibility of potentially replacing multiple di
Read more news
Top Hospitals & Physicians Clinics Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Radboudumc
Sign Up For FreeTo access detailed company insights
Radboudumc is one of eight University Medical Centres in The Netherlands, founded in 1951. The institution is devoted to patient care, education, training, and conducting basic and clinical research. Radboudumc focuses on delivering participatory and personalized healthcare through innovative medical services and research and development initiative... Read More
